Investment from Randox helps fast-track Verv Technologies’ home blood testing kit toward market
Sudbury medical technology company, that’s looking to commercialize a home blood testing kit, has secured $3.8 million from its leading investor in the United Kingdom.
Verv Technologies announced this week of the seed round funding from Randox Laboratories, a globally recognized biotechnology and laboratory services leader.
Established in 2012, Verv’s founder president Jeff Sutton hatched the idea of a consumer-oriented, disposable blood testing kit more than a decade ago and has devoted his efforts toward developing this technology, called the Verv Vi.
To conduct a blood test, a user places a drop of blood onto a disposable test strip, which is then inserted into the Vi.